64x Bio logo

64x Bio

Enabling next generation medicines. A comprehensive platform and…
San Francisco , US
Gene Therapy
Machine Learning
The future of medicine is taking shape, but scaling it remains a challenge. Some of the biggest breakthroughs in next generation therapies are being held back by manufacturing constraints. The science is moving fast, but the infrastructure is still catching up. Our VectorSelect platform is designed to unlock the scale these therapies need to survive. We combine massively parallelized screens with computational insights to engineer high yield cell lines and production technologies — accelerating the manufacturing of advanced therapies from the inside out.
Founded2017
Team Size25
LocationUS
🏳️
Is this your company?

Claim this listing to manage your profile, add updates, and connect with your audience.

Claim This Listing
  • Team
  • Jobs
  • News
Lexi Rovner
Lexi Rovner

Co-founder & CEO

Related Companies